Empagliflozin vs Raltegravir Potassium
Empagliflozin vs Raltegravir Potassium: Overview
This comparison examines the pharmacological differences between Empagliflozin and Raltegravir Potassium.
Mechanism of Action
Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.
Pharmacokinetics
Half-life: Empagliflozin — 12.4 hours.
Chemical Properties
Molecular Formula: Empagliflozin — C23H27ClO7.
Molecular Weight: Empagliflozin — 450.9100 g/mol.
Type: Empagliflozin — Small molecule; Raltegravir Potassium — Small molecule.